HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert Gray Selected Research

Robert Gray Research Topics

Disease

15Neoplasms (Cancer)
01/2022 - 10/2003
12Breast Neoplasms (Breast Cancer)
12/2019 - 07/2003
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2009 - 10/2003
2Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 10/2015
2Congenital Heart Defects (Congenital Heart Defect)
01/2019 - 11/2016
2Noninfiltrating Intraductal Carcinoma (DCIS)
11/2015 - 05/2013
2Hematoma
01/2012 - 01/2010
2Embolism (Embolus)
01/2012 - 01/2010
2Infections
01/2012 - 01/2010
2Phlebitis
01/2012 - 01/2010
2Peripheral Nerve Injuries
01/2012 - 01/2010
2Hemorrhage
03/2009 - 12/2006
1Fatigue
01/2022
1Pain (Aches)
01/2022
1COVID-19
02/2021
1Hyperlipidemias (Hyperlipidemia)
01/2021
1Obesity
12/2020
1Fibrosis (Cirrhosis)
10/2020
1Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2020
1Wounds and Injuries (Trauma)
01/2018
1Neoplasm Metastasis (Metastasis)
01/2017
1Wrist Fractures
12/2016
1Hemolytic Anemia
12/2015
1Thrombosis (Thrombus)
12/2015
1Opiate Overdose
11/2014
1Margins of Excision
05/2013
1Night Blindness (Nyctalopia)
12/2011
1Triple Negative Breast Neoplasms
11/2011
1Superior Vena Cava Syndrome (Superior Vena Cava Obstruction)
12/2008
1Disease Progression
12/2006
1Asthma (Bronchial Asthma)
04/2004
1Head and Neck Neoplasms (Head and Neck Cancer)
02/2004
1Colorectal Neoplasms (Colorectal Cancer)
02/2004

Drug/Important Bio-Agent (IBA)

7Hormones (Hormone)IBA
12/2019 - 09/2008
6Bevacizumab (Avastin)FDA Link
10/2009 - 02/2004
5Paclitaxel (Taxol)FDA LinkGeneric
10/2009 - 12/2006
4TamoxifenFDA LinkGeneric
01/2017 - 12/2011
4Pharmaceutical PreparationsIBA
01/2012 - 04/2002
4Carboplatin (JM8)FDA LinkGeneric
03/2009 - 12/2006
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2017
3Estrogen ReceptorsIBA
01/2017 - 05/2009
3RNA (Ribonucleic Acid)IBA
07/2012 - 12/2009
3Doxorubicin (Adriamycin)FDA LinkGeneric
11/2011 - 07/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2008 - 02/2004
2ErbB Receptors (EGF Receptor)IBA
12/2018 - 06/2007
2AnthracyclinesIBA
11/2011 - 12/2009
2Monoclonal AntibodiesIBA
12/2006 - 02/2004
1SolutionsIBA
02/2021
1OilsIBA
01/2021
1FatsIBA
01/2021
1Triglycerides (Triacylglycerol)IBA
01/2021
1Oil AIBA
01/2021
1oxidized low density lipoproteinIBA
01/2021
1IsotopesIBA
01/2021
1Lipoproteins (Lipoprotein)IBA
01/2021
1Palmitic Acid (Hexadecanoic Acid)IBA
01/2021
1Sucrose (Saccharose)IBA
12/2020
1Bleomycin (Blenoxane)FDA LinkGeneric
10/2020
1itaconic acidIBA
10/2020
1Co-Repressor ProteinsIBA
10/2020
1TensinsIBA
10/2020
1Proteins (Proteins, Gene)FDA Link
10/2020
1MutS ProteinsIBA
10/2020
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2020
1MutL Protein Homolog 1IBA
10/2020
1DNA (Deoxyribonucleic Acid)IBA
10/2020
1Messenger RNA (mRNA)IBA
01/2017
1Letrozole (Femara)FDA LinkGeneric
01/2017
1Nucleosomes (Nucleosome)IBA
12/2015
1LipidsIBA
10/2015
1Naloxone (Narcan)FDA LinkGeneric
11/2014
1Narcotic Antagonists (Opioid Antagonists)IBA
11/2014
1Biological ProductsIBA
07/2012
1FenretinideIBA
12/2011
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2011
1human ERBB2 proteinIBA
12/2009
1Interleukin-6 (Interleukin 6)IBA
05/2009
1Estrogens (Estrogen)FDA Link
05/2009
1E-SelectinIBA
03/2008
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
03/2008
1Cell Adhesion MoleculesIBA
03/2008
1PlatinumIBA
01/2008
1Tyrosine Kinase InhibitorsIBA
06/2007
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2004
1Angiogenesis InhibitorsIBA
02/2004

Therapy/Procedure

11Drug Therapy (Chemotherapy)
12/2019 - 07/2003
7Therapeutics
01/2022 - 10/2003
5Adjuvant Chemotherapy
12/2019 - 07/2003
2Segmental Mastectomy (Lumpectomy)
12/2018 - 11/2015
2Radiotherapy
12/2018 - 07/2012
1Stents
01/2019
1Laparotomy
01/2018
1Combination Drug Therapy (Combination Chemotherapy)
01/2017
1Operative Surgical Procedures
12/2016
1Pediatric Anesthesia
11/2016
1Anesthesia
11/2016
1Cardiac Procedures Anesthesia
11/2016
1Minimally Invasive Surgical Procedures
05/2013
1Chest Tubes (Chest Tube)
12/2008
1Aftercare (After-Treatment)
06/2007